The Triple Combination of Recombinant Methioninase, Rapamycin, and Chloroquine Synergistically Eradicates HCT116 Colon Cancer Cells
Anticancer Research · 2025
DOI: 10.21873/anticanres.17646 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Jinsoo Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: AntiCancer Inc., San Diego, CA, U.S.A. Hauptthemen laut MEDLINE: Carbon-Sulfur Lyases, Colonic Neoplasms, Sirolimus, Chloroquine.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- AntiCancer Inc., San Diego, CA, U.S.A.
- Department of Surgery, University of California, San Diego, CA, U.S.A.
- Department of Surgery, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.
- AntiCancer Inc., San Diego, CA, U.S.A. all@anticancer.com.
Zitieren
APA
Kim, J., Han, Q., Kang, B. M., Mizuta, K., Asano, Y., Bouvet, M., & Hoffman, R. M. (2025). The Triple Combination of Recombinant Methioninase, Rapamycin, and Chloroquine Synergistically Eradicates HCT116 Colon Cancer Cells. Anticancer Research. https://doi.org/10.21873/anticanres.17646
Vancouver
Kim J, Han Q, Kang BM, Mizuta K, Asano Y, Bouvet M, et al. The Triple Combination of Recombinant Methioninase, Rapamycin, and Chloroquine Synergistically Eradicates HCT116 Colon Cancer Cells. Anticancer Research. 2025. doi:10.21873/anticanres.17646
BibTeX
@article{Kim2025,
author = {Kim, Jinsoo and Han, Qinghong and Kang, Byung Mo and Mizuta, Kohei and Asano, Yohei and Bouvet, Michael and Hoffman, Robert M},
title = {The Triple Combination of Recombinant Methioninase, Rapamycin, and Chloroquine Synergistically Eradicates HCT116 Colon Cancer Cells},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17646}
}
EUVIMED